News for vTv Therapeutics Inc. (5VT.F)

As February comes to a close, we are seeing more volatility than ever among both blue chip and penny stocks. To understand why let’s take a look at some of th...

Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300 CIK : 0001641489 (se...

Today's Daily Dose brings you news about Nektar's collaboration with Merck; Pfizer initiating a refractory multiple myeloma study; Processa Pharma's strategic financing; and vTv Therapeutics' initiation of a phase 1 multiple ascending dose study of HPP737.

Phase 1 multiple ascending dose study to evaluate safety of HPP737 in healthy volunteers and inform dose selection for phase 2 planned for 2H 2021 Strategic ...

Penny Stocks Heating Up Scanners This Week As New Trends Take Hold There’s no denying that 2021 has been a banner year already, and we’re only about a mont...